Addex Therapeutics Ltd (ADXN)

Addex Therapeutics Statistics

Total Valuation

ADXN has a market cap or net worth of $6.65 million. The enterprise value is $3.92 million.

Market Cap	6.65M
Enterprise Value	3.92M

Important Dates

The next estimated earnings date is Thursday, June 18, 2026, before market open.

Earnings Date	Jun 18, 2026
Ex-Dividend Date	n/a

Share Statistics

ADXN has 144.59 million shares outstanding. The number of shares has increased by 16.24% in one year.

Current Share Class	n/a
Shares Outstanding	144.59M
Shares Change (YoY)	+16.24%
Shares Change (QoQ)	+28.33%
Owned by Insiders (%)	19.09%
Owned by Institutions (%)	2.13%
Float	92.72M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	30.47
Forward PS	n/a
PB Ratio	0.88
P/TBV Ratio	0.88
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	17.98
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-175.94

Financial Efficiency

Return on equity (ROE) is -87.53% and return on invested capital (ROIC) is -22.39%.

Return on Equity (ROE)	-87.53%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-22.39%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	14.65%
Revenue Per Employee	$109,087
Profits Per Employee	-$4.24M
Employee Count	2
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -17.76% in the last 52 weeks. The beta is 1.87, so ADXN's price volatility has been higher than the market average.

Beta (5Y)	1.87
52-Week Price Change	-17.76%
50-Day Moving Average	6.66
200-Day Moving Average	7.99
Relative Strength Index (RSI)	53.42
Average Volume (20 Days)	3,971

Short Selling Information

The latest short interest is 4,990, so 0.48% of the outstanding shares have been sold short.

Short Interest	4,990
Short Previous Month	7,260
Short % of Shares Out	0.48%
Short % of Float	n/a
Short Ratio (days to cover)	0.86

Income Statement

In the last 12 months, ADXN had revenue of $218,173 and -$8.49 million in losses. Loss per share was -$0.07.

Revenue	218,173
Gross Profit	218,173
Operating Income	-3.55M
Pretax Income	-8.63M
Net Income	-8.49M
EBITDA	-3.55M
EBIT	-3.55M
Loss Per Share	-$0.07

Balance Sheet

The company has $2.76 million in cash and $46,092 in debt, with a net cash position of $2.71 million or $0.02 per share.

Cash & Cash Equivalents	2.76M
Total Debt	46,092
Net Cash	2.71M
Net Cash Per Share	$0.02
Equity (Book Value)	7.51M
Book Value Per Share	0.06
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	539
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	100.00%
Operating Margin	-1,627.17%
Pretax Margin	-3,955.48%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ADXN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.24%
Shareholder Yield	-16.24%
Earnings Yield	-127.67%
FCF Yield	n/a

Analyst Forecast

The average price target for ADXN is $38.12, which is 445.35% higher than the current price. The consensus rating is "Buy".

Price Target	$38.12
Price Target Difference	445.35%
Analyst Consensus	Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 23, 2023. It was a reverse split with a ratio of 1:20.

Last Split Date	Oct 23, 2023
Split Type	Reverse
Split Ratio	1:20

Scores

Altman Z-Score	n/a
Piotroski F-Score	1